Page last updated: 2024-11-12

demethoxyfumitremorgin c

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

demethoxyfumitremorgin C: isolated from the fermentation broth of Aspergillus fumigatus; a mammalian cell cycle inhibitor; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

demethoxyfumitremorgin C : An organic heteropentacyclic compound that is a mycotoxic indole alkaloid, consisting of fumitremorgin C lacking the 9-methoxy substituent. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10337896
CHEMBL ID39346
CHEBI ID72767
SCHEMBL ID6418225
MeSH IDM0264219

Synonyms (13)

Synonym
(5as,12s,14as)-12-(2-methylprop-1-en-1-yl)-1,2,3,5a,6,11,12,14a-octahydro-5h,14h-pyrrolo[1'',2'':4',5']pyrazino[1',2':1,6]pyrido[3,4-b]indole-5,14-dione
demethoxyfumitremorgin c
CHEMBL39346
chebi:72767 ,
(5as,12s,14as)-12-(2-methylprop-1-en-1-yl)-1,2,3,5a,6,14a-hexahydropyrrolo[1'',2'':4',5']pyrazino[1',2':1,6]pyrido[3,4-b]indole-5,14(11h,12h)-dione
SCHEMBL6418225
111768-16-2
Q27140133
FS-8835
(1s,12s,15s)-12-(2-methylprop-1-enyl)-10,13,19-triazapentacyclo[11.7.0.03,11.04,9.015,19]icosa-3(11),4,6,8-tetraene-14,20-dione
AKOS040763125
HY-N7569
CS-0133911
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
mycotoxinPoisonous substance produced by fungi.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
indole alkaloidAn alkaloid containing an indole skeleton.
organic heteropentacyclic compound
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
fumitremorgin C biosynthesis518
superpathway of fumitremorgin biosynthesis925

Bioassays (18)

Assay IDTitleYearJournalArticle
AID50745Inhibitory activity against Colon cell line2000Journal of medicinal chemistry, Apr-20, Volume: 43, Issue:8
Synthesis and evaluation of tryprostatin B and demethoxyfumitremorgin C analogues.
AID219153Inhibitory activity against breast cell line2000Journal of medicinal chemistry, Apr-20, Volume: 43, Issue:8
Synthesis and evaluation of tryprostatin B and demethoxyfumitremorgin C analogues.
AID46129Inhibitory activity against CNS cell line2000Journal of medicinal chemistry, Apr-20, Volume: 43, Issue:8
Synthesis and evaluation of tryprostatin B and demethoxyfumitremorgin C analogues.
AID222036Inhibitory activity against melanoma cell line2000Journal of medicinal chemistry, Apr-20, Volume: 43, Issue:8
Synthesis and evaluation of tryprostatin B and demethoxyfumitremorgin C analogues.
AID223673Inhibitory activity against prostate cell line2000Journal of medicinal chemistry, Apr-20, Volume: 43, Issue:8
Synthesis and evaluation of tryprostatin B and demethoxyfumitremorgin C analogues.
AID1336110Inhibition of BCRP in human K562 cells assessed as potentiation of SN38-mediated growth inhibition at 3 uM after 4 days by coulter counter method2016Bioorganic & medicinal chemistry letters, 12-15, Volume: 26, Issue:24
Biosynthetic approaches to creating bioactive fungal metabolites: Pathway engineering and activation of secondary metabolism.
AID3429Mean concentration causing inhibition of cell growth in 3Y1 cells.2000Journal of medicinal chemistry, Apr-20, Volume: 43, Issue:8
Synthesis and evaluation of tryprostatin B and demethoxyfumitremorgin C analogues.
AID221031Inhibitory activity against leukemia cell line2000Journal of medicinal chemistry, Apr-20, Volume: 43, Issue:8
Synthesis and evaluation of tryprostatin B and demethoxyfumitremorgin C analogues.
AID3430Cytotoxicity in 3Y1 cells.2000Journal of medicinal chemistry, Apr-20, Volume: 43, Issue:8
Synthesis and evaluation of tryprostatin B and demethoxyfumitremorgin C analogues.
AID423399Induction of neurite outgrowth in rat PC12 cells at 10 uM after 2 days by phase-contrast microscope2009Journal of natural products, Apr, Volume: 72, Issue:4
Bioactive alkaloids from endophytic Aspergillus fumigatus.
AID423397Cytotoxicity against human K562 cells after 48 hrs by MTT assay2009Journal of natural products, Apr, Volume: 72, Issue:4
Bioactive alkaloids from endophytic Aspergillus fumigatus.
AID423398Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay2009Journal of natural products, Apr, Volume: 72, Issue:4
Bioactive alkaloids from endophytic Aspergillus fumigatus.
AID423396Cytotoxicity against human KB cells after 48 hrs by MTT assay2009Journal of natural products, Apr, Volume: 72, Issue:4
Bioactive alkaloids from endophytic Aspergillus fumigatus.
AID146692Inhibitory activity against NSL cell line2000Journal of medicinal chemistry, Apr-20, Volume: 43, Issue:8
Synthesis and evaluation of tryprostatin B and demethoxyfumitremorgin C analogues.
AID3431Cytostatic effect in 3Y1 cells.2000Journal of medicinal chemistry, Apr-20, Volume: 43, Issue:8
Synthesis and evaluation of tryprostatin B and demethoxyfumitremorgin C analogues.
AID228401Inhibitory activity against renal cell line2000Journal of medicinal chemistry, Apr-20, Volume: 43, Issue:8
Synthesis and evaluation of tryprostatin B and demethoxyfumitremorgin C analogues.
AID1336111Inhibition of BCRP (unknown origin)-dependent ATPase activity at 50 uM after 30 mins by malachite green method2016Bioorganic & medicinal chemistry letters, 12-15, Volume: 26, Issue:24
Biosynthetic approaches to creating bioactive fungal metabolites: Pathway engineering and activation of secondary metabolism.
AID223646Inhibitory activity against ovarian cell line2000Journal of medicinal chemistry, Apr-20, Volume: 43, Issue:8
Synthesis and evaluation of tryprostatin B and demethoxyfumitremorgin C analogues.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (20.00)18.2507
2000's6 (60.00)29.6817
2010's2 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.97 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (30.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (70.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]